Home R&D Page 10

R&D

First oral treatment for Fabry disease recommended for approval in the...

Space and Technology. Drug development at the International Space Station

Empagliflozin: new results showing the reduction of cardiovascular events

ODYSSEY: a study to assess the potenital cardiovascular benefit of alirocumab

Conditional approval for blinatumomab to treat B-precursor ALL

Mepolizumab in the treatment of asthma

First digital medicine application accepted by FDA

Clinical research

Children are not small adults

Almost all drugs used for the treatment of childhood cancer have not been studied in the pediatric population

Guanfacine to treat attention deficit hyperactivity disorder

Alirocumab to treat adults with primary hypercholesterolaemia

1...91011...16Page 10 of 16
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151